PHT Corporation Launches New App of FDA Roadmap to Patient-Focused Outcome Measurement in Clinical Trials for Android Phones and Tablets
The FDA Roadmap enables researchers involved in patient-centric trials to navigate FDA clinical outcome assessment qualification program
Presented by
PHT’s new mobile app optimizes the roadmap for android phones and tablets. You can download the android app and view the mobile web version here:
Watch a short demo of the PHT Roadmap App here:
The purpose of the FDA roadmap is to help trial sponsors improve clinical research that collects patient data through understanding the disease or condition, conceptualizing the treatment benefit resulting in identification of the targeted context of use (COU) and concept of interest (COI) for future clinical trial measurement.
PHT Vice President of Marketing and Product Management Sheila Rocchio, MBA, said, “Clinical trials are including more patient reported outcomes (PROs) since the publication of the
The Roadmap App is another example of PHT innovation in mobile technology for clinical research. The PHT
Learn about the latest PRO and eCOA innovations, case studies and best practices at the 2014 PRO & eCOA Congress at
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025